Methotrexate in chronic active Crohn's disease: A double-blind, randomized, Israeli multicenter trial

American Journal of Gastroenterology

Volumn 92, Issue 12 SUPPL., 1997, Pages 2203-2209

  Oren, Ran ^b   Moshkowitz, Menachem ^b   Odes, Shmuel ^b   Becker, Stuart ^b   Keter, Daniel ^b   Pomeranz, Itamar ^b   Shirin, Chaim ^b   Reisfeld, Ilan ^b   Broide, Efrat ^b   Lavy, Alexandra ^b   Fich, Alexander ^b   Eliakim, Rami ^b   Patz, Julian ^b   Villa, Yael ^b   Arber, Nadir ^b   Gilat, Tuvia ^a  

^a Ichilov Medical Center   (Israel)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; MERCAPTOPURINE; METHOTREXATE; PLACEBO; STEROID;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; ISRAEL; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; REMISSION; STEROID THERAPY; TREATMENT OUTCOME;

6-MERCAPTOPURINE; ABDOMINAL PAIN; ADMINISTRATION, ORAL; ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIRHEUMATIC AGENTS; CHRONIC DISEASE; CROHN DISEASE; DOUBLE-BLIND METHOD; EVALUATION STUDIES; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISRAEL; MALE; MESALAMINE; METHOTREXATE; MIDDLE AGED; PLACEBOS; RECURRENCE; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 0030784425     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Present DH, Korelitz BI, Wisch N, et al. Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double blind study. N Engl J Med 1980;302:981-7.
2. Korelitz BI, Adler DJ, Mendelsohn RA, et al. Long-term experience with 6-mercaptopurine in the treatment of Crohn's disease. Am J Gastroenterol 1993;88:1198-205.
3. Korelitz BI, Present DH. Favorable effect of 6-mercaptopurine on fistulae of Crohn's disease. Dig Dis Sci 1985;30:58-64.
4. Goldstein F. Immunosuppressant therapy of inflammatory bowel disease. Pharmacologic and clinical aspects. J Clin Gastroenterol 1987; 6:654-8.
5. Hodgson HJ. Cyclosporin in inflammatory bowel disease. Aliment Pharmacol Ther 1991;5:343-50.
6. Brynskov J, Freund L, Rasmussen SN, et al. Placebo controlled, double-blind, randomized trial of Cyclosporin therapy in active chronic Crohn's disease. N Engl J Med 1989;321:845-50.
7. Sachar DB. Cyclosporin treatment for inflammatory bowel disease. N Engl J Med 1989;321:845-50.
8. Lichtiger S. Cyclosporin therapy in inflammatory bowel disease. Mt Sinai J Med 1990;57:315-9.
9. Kozarek RA, Patterson DJ, Gelfand MD, et al. Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease. Ann Intern Med 1989;110:353-6.
10. Williams HJ, Willkens RF, Samuelson CO Jr, et al. Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. Arthritis Rheum 1985;28:721-30.
11. Yaron M. Editor, Methotrexate for rheumatoid arthritis. Sackler Faculty of Medicine Publications, Tel Aviv, 1990.
12. Weinblatt ME, Weissman BN, Holdsworth DE, et al. Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis. Arthritis Rheum 1992;35:129-37.
13. Black RL, O'Brien WM, Van Scott EJ, et al. Methotrexate therapy in psoriatic arthritis. JAMA 1964;189:743-7.
14. Mullarkey MF, Blumentstein BA, Andrade WP, et al. Methotrexate in the treatment of corticosteroid-dependent asthma: A double blind crossover study. N Engl J Med 1988;318:603-7.
15. Kaplan MM, Knox TA, Arora S. Primary biliary cirrhosis treated with low-dose oral methotrexate. Ann Intern Med 1988;109:429-31.
16. Knox TA, Kaplan MM. A double-blind controlled trial of oral-pulse methotrexate therapy in the treatment of primary sclerosing cholangitis. Gastroenterology 1994;106:494-9.
17. Kremer JM, Phelps CT. Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis: Update after a mean of 90 months. Arthritis Rheum 1992;35:138-45.
18. Feagan BG, Rochon J, Fedorak RN, et al. Methotrexate for the treatment of Crohn's disease. N Engl J Med 1995;332:292-7.
19. Baron TH, Truss CD, Elson CO. Low-dose oral methotrexate in refractory inflammatory bowel disease. Dig Dis Sci 1993;38:1851-6.
20. Arora S, Katkov WN, Cooley J, et al. A double blind, randomized, placebo-controlled trial of methotrexate in Crohn's disease. Gastroenterology 1992;102:A591.
21. Malchow H, Ewe K, Brandes JW. European Cooperative Crohn's Disease Study (ECCDS): Results of drug treatment. Gastroenterology 1984;86:249-66.
22. Myren J, Bouchier AE, Watkinson G, et al. The OMGE Multinational Inflammatory Bowel Disease Survey. Scand J Gastroenterol 1984; 19(suppl 5):1-27.
23. Moshkovitz M, Oren R, Tishler M, et al. The absorption of low dose methotrexate in patients with inflammatory bowel disease. Aliment Pharmacol Ther 1997; 11:569-73.
24. Oren R, Arber N, Odes S, et al. Methotrexate in chronic ulcerative colitis: A double blind randomized multicenter Israeli trial. Gastroenterology 1996;110:1416-21.
25. Chamiot-Prieur C, Lenann M, Mesnard B, et al. Treatment of refractory Crohn's disease with Methotrexate. Gastroenterology 1993;104: A680 (abstract).